NSE · TIRUMALCHM
Thirumalai Chemicals Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹331 Cr with net profit ₹14 Cr — a 4.3% net margin, versus -9.57% the period before.
Shareholding
As of 2026-09-30
- Promoter37.13%
- Public55.35%
- FII1.39%
- DII6.13%
58,355 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.5× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #56 of 161 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹1,69,063 Cr | 84.9 | 26.96 | 26.72% | 17.54% |
| Pidilite Industries Ltd. | ₹1,50,540 Cr | 56.85 | 13.89 | 22.61% | 17.2% |
| SRF Ltd. | ₹69,363 Cr | 29.37 | 4.53 | 14.92% | 12.76% |
| Linde India Limited | ₹48,036 Cr | 87.91 | 11.26 | 12.87% | 20.59% |
| Gujarat Fluorochemicals Ltd. | ₹46,105 Cr | 74.64 | 5.89 | 7.13% | 11.41% |
| Navin Fluorine International Ltd. | ₹39,317 Cr | 49.44 | 9.9 | 16.69% | 21.73% |
| Godrej Industries Ltd. | ₹31,977 Cr | 26.14 | 2.86 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹26,351 Cr | 30.83 | 5.13 | 16.65% | 15.28% |
| Deepak Nitrite Ltd. | ₹19,675 Cr | 24.84 | 3.37 | 9.43% | 9.13% |
| Aether Industries Limited | ₹19,531 Cr | 81.39 | 7.96 | 8.94% | 19.11% |
| Thirumalai Chemicals Ltd.(this company) | ₹1,427 Cr | — | 0.92 | -10.74% | -8.28% |
AI analysis
AI-generated · google/gemini-2.5-flashThirumalai Chemicals Ltd. is listed with a market capitalization of Rs 1958 Cr. The company reported revenue of Rs 1754.23 Cr and a profit margin of -9.67%. Its debt-to-equity ratio stands at 1.46. The Return on Equity (ROE) is -10.74% and Return on Capital Employed (ROCE) is -2.87%.
Positives
- +No promoter pledge is reported (0%).
- +The number of shareholders has increased over time, from 18,871 as of Mar 2017 to 56,739 as of Mar 2026.
Negatives
- −Revenue decreased by -1.6%.
- −The company reported a negative profit margin of -9.67%.
- −Return on Equity (ROE) is -10.74%.
- −Return on Capital Employed (ROCE) is -2.87%.
- −The debt-to-equity ratio is high at 1.46.
- −The company has reported negative net profits consistently across all available quarterly data, such as -46.57 Cr in Dec 2025 and an annual net profit of -167.91 Cr for Mar 2026.
- −The Earnings Per Share (EPS) for the year ending Mar 2026 is negative at -14.91.
Financial Performance
Thirumalai Chemicals Ltd. reported revenue of Rs 1754.23 Cr, representing a revenue growth of -1.6%. The company's net profit for the year ending Mar 2026 was -167.91 Cr, with an EPS of -14.91 for the same period. Quarterly revenue for Dec 2025 was Rs 415.85 Cr, with a net profit of -46.57 Cr.
Profitability & Returns
The company's profitability is negative, with a profit margin of -9.67%. Return on Equity (ROE) is -10.74% and Return on Capital Employed (ROCE) is -2.87%, indicating that the company is not generating positive returns from its equity or capital employed. The EPS for the year ending Mar 2026 was -14.91.
Balance Sheet
Thirumalai Chemicals Ltd. has a debt-to-equity ratio of 1.46, indicating a significant reliance on debt financing. The book value per share is Rs 129.7. There is no dividend yield reported for the company (0%).
Ownership & Pledges
As of March 31, 2026, promoter holding in Thirumalai Chemicals Ltd. is 37.13%. The public shareholding stands at 50.87%. No promoter shares are reported as pledged.
Data as of — price: 2026-10-27 · financials: Jun 26 · shareholding: Sep 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.